SGLT2抑制可正常化糖尿病小鼠肾脏糖代谢并抑制氧化应激
研究探讨长期SGLT2抑制对糖尿病肾脏的影响,在22周龄BTBR ob/ob糖尿病小鼠中评估伊格列净与30%热量限制对肾脏糖代谢的作用。质谱代谢组学显示糖尿病小鼠肾脏三羧酸循环代谢物异常升高,SGLT2抑制和热量限制几乎完全消除该异常及皮质柠檬酸蓄积和氧化型谷胱甘肽积累,并改善肾小球损伤如白蛋白尿、肾小球高滤过和系膜扩张;仅热量限制改善小管间质巨噬细胞浸润和纤维化,可能与自噬激活有关。
要点
- SGLT2抑制可正常化糖尿病肾脏三羧酸循环代谢物蓄积和氧化应激。
- SGLT2抑制改善白蛋白尿、肾小球高滤过和系膜扩张。
- 仅热量限制改善小管间质巨噬细胞浸润和纤维化,或与自噬激活相关。
核心结论
- 长期SGLT2抑制可有效正常化糖尿病小鼠肾脏中蓄积的三羧酸循环中间产物和增加的氧化应激。
研究设计与样本
- 研究在22周龄BTBR ob/ob糖尿病小鼠中开展,采用基于质谱的代谢组学和成像质谱,评估慢性SGLT2抑制(伊格列净)与30%热量限制(两者降糖程度相似)对肾脏葡萄糖代谢的累积效应。
主要发现
- 糖尿病小鼠肾脏三羧酸循环代谢物池异常升高,SGLT2抑制和热量限制几乎完全消除该异常。
- 成像质谱显示糖尿病小鼠肾皮质柠檬酸(三羧酸循环中间产物)水平增加,SGLT2抑制和热量限制几乎完全消除皮质柠檬酸蓄积。
- 成像质谱显示肾皮质(尤其肾小球)氧化型谷胱甘肽蓄积,SGLT2抑制和热量限制可消除该蓄积。
- SGLT2抑制和热量限制的有益效应与肾小球损伤改善(如白蛋白尿、肾小球高滤过和系膜扩张)一致。
- 小管间质巨噬细胞浸润和纤维化仅被热量限制改善,可能与仅在热量限制中观察到的自噬激活有关。
临床怎么用
- 糖尿病肾病患者使用SGLT2抑制剂可能通过正常化肾脏糖代谢和抑制氧化应激发挥肾脏保护作用。
局限性
- 研究为糖尿病小鼠模型,结论外推至人类需谨慎。
- 热量限制改善小管间质病变的机制(自噬激活)与SGLT2抑制不同,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
It is unclear whether long-term sodium-glucose cotransporter 2 (SGLT2) inhibition such as that during the treatment of diabetes has deleterious effects on the kidney. Therefore, we first sought to determine whether abnormal glucose metabolism occurs in the kidneys of 22-week-old BTBR ob/ob diabetic mice. Second, the cumulative effect of chronic SGLT2 inhibition by ipragliflozin and 30% calorie restriction, either of which lowered blood glucose to a similar extent, on renal glucose metabolism was evaluated. Mass spectrometry-based metabolomics demonstrated that these diabetic mice exhibited an abnormal elevation in the renal pools of tricarboxylic acid cycle metabolites. This was almost completely nullified by SGLT2 inhibition and calorie restriction. Moreover, imaging mass spectrometry indicated an increased level of the tricarboxylic acid cycle intermediate, citrate, in the cortex of the diabetic mice. SGLT2 inhibition as well as calorie restriction almost completely eliminated citrate accumulation in the cortex. Furthermore, imaging mass spectrometry revealed that the accumulation of oxidized glutathione in the cortex of the kidneys, prominent in the glomeruli, was also canceled by SGLT2 inhibition and calorie restriction. Effects of these beneficial interventions were consistent with improvements in glomerular damage, such as albuminuria, glomerular hyperfiltration, and mesangial expansion. Tubulointerstitial macrophage infiltration and fibrosis were ameliorated only by calorie restriction, which may have been due to autophagy activation, which was observed only with calorie restriction. Thus, chronic SGLT2 inhibition is efficient in normalizing the levels of accumulated tricarboxylic acid cycle intermediates and increased oxidative stress in the kidneys of diabetic mice.
引用
- Tanaka S, Sugiura Y, Saito H, et al. Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice. Kidney Int. 2018. PMID: 30021702. doi:10.1016/j.kint.2018.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。